CELIXIR
LIVE

Serial Number

79205912

Owner

Cell Therapy Limited

Attorney

Bess Morgan

Filing Date

Jan 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

CELIXIR Trademark

Serial Number: 79205912 • Registration: 5420465

CELIXIR is a trademark filed by Cell Therapy Limited on January 12, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cell Therapy Limited (5 trademarks)

The Maynard Centre

Entity Type: 99

Trademark Details

Filing Date

January 12, 2017

Registration Date

March 13, 2018

Published for Opposition

December 26, 2017

Cancellation Date

September 27, 2024

Goods & Services

Pharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 2, 2025 INTS
INVALIDATION PROCESSED
Oct 2, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 27, 2025 INTR
CANCELLED SECTION 71
Sep 27, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 13, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 20, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Jun 21, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2017 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2017 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 16, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 14, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 14, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 14, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 14, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 17, 2017 GNFN
FINAL REFUSAL E-MAILED
Aug 17, 2017 GNFR
FINAL REFUSAL WRITTEN
Aug 17, 2017 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2017 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 4, 2017 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 25, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 25, 2017 TROA
REFUSAL PROCESSED BY IB
Jun 3, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 16, 2017 RFCS
REFUSAL PROCESSED BY MPU
May 16, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 9, 2017 RFCR
NON-FINAL ACTION WRITTEN
May 8, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
May 5, 2017 MAFR
ASSIGNED TO EXAMINER
May 1, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 27, 2017 REPR